These results suggest that deguelin directly targets Bmi1 to inhibit its binding to the Noxa promoter and relieves Bmi1‐mediated Noxa repression to increase Noxa expression, leading to deguelin‐induced apoptosis in NSCLC cells. The gene discussed is BMI1; the disease is non-small cell lung carcinoma.